Skip to content

The Effect of Pelvic Floor Physiotherapy on Vaginal Elasticity

The Effect of Pelvic Floor Physiotherapy on Vaginal Elasticity as Measured by a Vaginal Tactile Imager

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04114019
Enrollment
0
Registered
2019-10-03
Start date
2020-07-01
Completion date
2021-04-01
Last updated
2020-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress Urinary Incontinence

Brief summary

Women suffering from stress urinary incontinence are offered pelvic floor physiotherapy as an optional treatment. Strengthening of the pelvic floor is measured to date by manual examination and lacks precise evaluation. The vaginal tactile imager assists in evaluation of the changes in the pelvic floor after physiotherapy.

Detailed description

Women with stress urinary incontinence will undergo 6-10 pelvic floor strengthening physiotherapy sessions. The participants will undergo a short examination of vaginal elasticity using a vaginal tactile imager prior to beginning physiotherapy and additional examinations after 6 treatments, 10 treatments and 3 and 6 months post-treatment cessation.

Interventions

DIAGNOSTIC_TESTVaginal tactile imager

Vaginal elasticity evaluation using a vaginal tactile imager

Sponsors

Rambam Health Care Campus
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* women suffering from stress urinary incontinence.

Exclusion criteria

* women suffering from urge urinary incontinence. * women suffering of mixed urinary incontinence.

Design outcomes

Primary

MeasureTime frameDescription
Vaginal ElasticityFrom the treatment cessation up to 6 months post-treatmentChanges in vaginal elasticity post physiotherapy

Secondary

MeasureTime frameDescription
Stress urinary incontinenceFrom the treatment cessation up to 6 months post-treatmentImprovement in the urogenital distress inventory questionnaire score (range 0-15)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026